What is Dimerix Ltd?
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 210.14M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.